CustomCustomCustomCustomCustomCustom

home2025-02-22T10:49:36+01:00

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

TAmiRNA - stability for live

Our Expertise:
RNA signatures and diagnostics

mircoRNA_signatures

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

TAmiRNA - stability for live

Our Focus:
biomarker discovery for complex diseases

age_associated_diseases

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

TAmiRNA - stability for live

biomarkers for more stability in life

Our Mission:
RNA biomarkers for precision medicine

discovery_and_validation_of_microRNA_biomarkers

TAmiRNA is dedicated to supporting researchers and clinicians in RNA biomarker discovery, validation, and development. Our mission is to provide innovative diagnostic solutions that improve patient outcomes, with a focus on precision medicine and age-associated diseases.

Our Focus:
biomarker discovery for complex diseases

mircoRNA_signatures

TAmiRNA drives R&D and contract research in liver disease, senescence, cardiovascular disease, oncology, and bone and joint disorders. Using advanced transcriptomic approaches, we aim to decode disease mechanisms, personalize diagnostics, and accelerate biomarker-driven innovations.

Our Expertise:
RNA signatures and diagnostics

We specialize in biomarker discovery using cell-free RNAs, including microRNAs, mRNAs, and long non-coding RNAs (lncRNAs). By integrating RNA signatures with AI-driven analysis, we develop actionable diagnostic solutions that enhance disease detection and patient stratification.

Services

Transcriptomic services

services

Exploring microRNAs, mRNAs, circular RNAs, or other non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) and untargeted (NGS-based) RNA analysis in serum, plasma, urine, saliva, milk, EVs, exosomes, cells, and tissues. With 11+ years of RNA biomarker expertise, we ensure reliable results and project success.

TAmiRNA - the power of microRNA biomarkers

RNA biomarker services

Interested in our microRNA disease panels or IVD/RUO kits but lack the time or resources for in-house analysis?

Send us your samples, and our in-house services will deliver results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, and thrombomiR®. We also support custom miRNA or mRNA signature analysis by implementing tailored workflows.

TAmiRNA - the power of microRNA biomarkers
Click_here_for_your_personalized_microRNA_service_offer

our services

RNA analysis services

services

You are interested in microRNAs, mRNAs, circular RNAs, as well as other small or long non-coding RNAs?

TAmiRNA offers validated solutions for targeted (RT-qPCR) as well as untargeted (transcriptomic) analysis of any RNA in serum, plasma, urine, saliva, EVs and exosomes, cells, and tissues. Our experience of 11+ years in RNA biomarker development ensure the success of our customer projects.

TAmiRNA - the power of microRNA biomarkers

Kit services

You are interested in our microRNA disease panels or IVD/RUO kits, but don´t have the time or resources to analyse in your lab?

You can send us your samples to obtain results for hepatomiR®, senomiR®, toxomiR®, osteomiR®, or thrombomiR® by taking advantage of our in-house services. In addition, we can support the analysis of your specific miRNA or mRNA signature by implementing a tailored workflow or kit.

TAmiRNA - the power of microRNA biomarkers
TAmiRNA - stability for live

Products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

our products

TAmiRNA - stability for live
TAmiRNA - stability for live
TAmiRNA - stability for live

latest news

hepatoMX Project Kickoff: TAmiRNA and You2Yourself Join Forces to Develop a Groundbreaking Urinary microRNA Diagnostic for Liver Disease

By |October 14th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, hepatoMX, Illumina NewSeq2000, microRNA services, microRNAs, miND, miND spike ins, NGS, sequencing, small RNA-sequencing, smallRNA|Tags: , , , , , , , , , , , |

We are excited to announce the official start of the EUREKA Eurostars project hepatoMX — a three-year collaboration between You2Yourself (Y2Y), a Dutch company specializing in small RNA-based early [...]

Read More
 0

Microvascular microRNA Signatures in Sepsis: A High-Resolution View

By |October 9th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, Illumina NewSeq2000, laser microdissection (LMD), microRNA services, microRNAs, miND, miND spike ins, NGS, sequencing, small RNA-sequencing, smallRNA|Tags: , , , , , , , , |

Sepsis drives profound microvascular injury, particularly in the kidney. But how do microRNAs (miRNAs) - the small regulators of gene expression - respond within distinct vascular compartments during this [...]

Read More
 0

TAmiRNA @ GSEV 2025

By |September 22nd, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, microRNAs, NGS, periprosthetic joint infections, small RNA-sequencing, Synovial fluid|Tags: , , , , , , , |

TAmiRNA Announces Gold Sponsorship of GSEV Autumn Meeting 2025 and Presentation by Matthias Hackl TAmiRNA, a pioneer in transcriptomics-based biomarker research, is proud to announce its participation as a [...]

Read More
Comments Off on TAmiRNA @ GSEV 2025

hepatoMX Project Kickoff: TAmiRNA and You2Yourself Join Forces to Develop a Groundbreaking Urinary microRNA Diagnostic for Liver Disease

By |October 14th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, hepatoMX, Illumina NewSeq2000, microRNA services, microRNAs, miND, miND spike ins, NGS, sequencing, small RNA-sequencing, smallRNA|Tags: , , , , , , , , , , , |

We are excited to announce the official start of the EUREKA Eurostars project hepatoMX — a three-year collaboration between You2Yourself (Y2Y), a Dutch company specializing in small RNA-based early disease detection, and [...]

Read More
 0

Microvascular microRNA Signatures in Sepsis: A High-Resolution View

By |October 9th, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, Illumina NewSeq2000, laser microdissection (LMD), microRNA services, microRNAs, miND, miND spike ins, NGS, sequencing, small RNA-sequencing, smallRNA|Tags: , , , , , , , , |

Sepsis drives profound microvascular injury, particularly in the kidney. But how do microRNAs (miRNAs) - the small regulators of gene expression - respond within distinct vascular compartments during this insult? A new [...]

Read More
 0

TAmiRNA @ GSEV 2025

By |September 22nd, 2025|Categories: biomarker, Biomarker Discovery, biomarkers, microRNAs, NGS, periprosthetic joint infections, small RNA-sequencing, Synovial fluid|Tags: , , , , , , , |

TAmiRNA Announces Gold Sponsorship of GSEV Autumn Meeting 2025 and Presentation by Matthias Hackl TAmiRNA, a pioneer in transcriptomics-based biomarker research, is proud to announce its participation as a Gold Sponsor at [...]

Read More
Comments Off on TAmiRNA @ GSEV 2025
© Copyright TAmiRNA 2019 - 
Go to Top